Shingles (Herpes Zoster): Prevention

As of March 2018, an adjuvanted subunit total vaccine (containing glycoprotein E of the pathogen) has been approved for the prevention of herpes zoster (HZ) and postherpetic neuralgia (PHN) in persons 50 years of age and older. This has a high protective effect even in older age groups and, in addition to good safety, has a longer duration of protection (at least 10 years).

The vaccination is a standard and indicated vaccination in Germany.

For the prevention of herpes zoster, attention must also be paid to reducing the risk factors.

Behavioral risk factors (= increased risk of zoster).

  • Consumption of stimulants
    • Alcohol
    • Tobacco (smoking, passive smoking)
  • Overweight (BMI ≥ 25; obesity).